ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 048,54
-0,21%
Dow Jones
38 386,09
0,38%
DAX
18 043,21
-0,49%
Brent Oil
87,375
0,10%
Bitcoin
61 658,85
-3,41%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Angion Biomedica Corporation (ANGN)

  7. Angion Biomedica Corporation (ANGN) Actualités

ANGN Angion Biomedica Corporation

10,00
0,00 (0,00%)
Avant marché
Dernière mise à jour : 02:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Angion Biomedica Corporation ANGN NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 10,00 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
10,00
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
29/4/202413:00EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
05/4/202422:33EDGAR2Form 8-K - Current report
29/3/202420:28EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/3/202420:26EDGAR2Form S-3 - Registration statement under Securities Act of..
29/3/202418:58EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/3/202413:35EDGAR2Form 8-K - Current report
20/3/202421:37EDGAR2Form SC 13D/A - General statement of acquisition of..
20/3/202421:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/3/202413:05EDGAR2Form 8-K - Current report
05/2/202412:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202412:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202412:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202412:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202414:51EDGAR2Form 8-K - Current report
17/1/202414:35EDGAR2Form 8-K - Current report
16/1/202413:59EDGAR2Form 8-K - Current report
09/1/202414:11EDGAR2Form 8-K - Current report
05/1/202422:05EDGAR2Form D - Notice of Exempt Offering of Securities
29/12/202323:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202323:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202322:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202322:25EDGAR2Form SC 13D/A - General statement of acquisition of..
22/12/202315:06EDGAR2Form 8-K - Current report
13/11/202314:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:41EDGAR2Form 8-K - Current report
03/11/202322:10EDGAR2Form 8-K - Current report
20/10/202313:58EDGAR2Form 8-K - Current report
12/10/202313:59EDGAR2Form 8-K - Current report
07/9/202314:00EDGAR2Form 8-K - Current report
30/8/202322:33EDGAR2Form 8-K - Current report
21/8/202323:30EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/8/202303:13EDGAR2Form 8-K/A - Current report: [Amend]
11/8/202317:42EDGAR2Form 8-K - Current report
07/7/202315:17EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/6/202314:00GLOBEAngion Biomedia Corp. Announces 1-for-10 Reverse Stock Split

Dernières Valeurs Consultées

NASDAQ
ANGN
Angion Biomedica
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés